MedTrace Logo

Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease

NCT00260572 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2026-04-14

No results posted yet for this study

Summary

The aims of this study are to create a prospective data base to evaluate the long term outcomes of medical and surgical treatment of gastroesophageal reflux disease (GERD); to measure standard outcomes as well as patient derived outcomes such as general and disease specific quality of life (QOL) issues and patient satisfaction; to refine the parameters that may identify patients who will benefit from surgery for GERD; and to identify possible determinants of failure of both medical and surgical treatments of reflux.

Conditions

  • Gastroesophageal Reflux Disease

Interventions

BEHAVIORAL

Questionnaires to evaluate QOL

Questionnaire to evaluate QOL administered preoperatively and postoperatively at set intervals.

BEHAVIORAL

Questionnaires to evaluate heartburn and quality of life

Questionnaires to evaluate heartburn and quality of life administered preoperatively and at set intervals postoperatively.

BEHAVIORAL

Questionnaire to evaluate satisfaction with treatment

Questionnaire administered postoperatively at set intervals.

BEHAVIORAL

Questionnaire to evaluate presence or absence of pain

Questionnaire administered preoperatively and at set intervals postoperatively.

Sponsors & Collaborators

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • James D. Luketich, MD · Department of Cardiothoracic Surgery

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-04-30
Primary Completion
2050-12-31
Completion
2050-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00260572 on ClinicalTrials.gov